Vessi Medical Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vessi Medical Ltd - overview
Established
2015
Location
-, -, Israel
Primary Industry
Medical Devices & Equipment
About
Based in Misgav, Israel, and founded in 2021 by CEO Eyal Kochavi, Vessi Medical Ltd operates as a developer of a medical device that is used to treat non-muscle-invasive bladder cancer (NMIBC). In February 2024, Vessi Medical Ltd. raised USD 16. 5 million in Series A funding co-led by ALIVE, Agriline Ltd, and Trendlines Group.
Vessi Medical Ltd developed a cryo spray system designed for hollow and humid organs, particularly the bladder. The company’s device utilizes surface cryotherapy to freeze and destroy abnormal tissue, ablating unwanted tissue while minimizing the risk of complications and preserving bladder integrity. In addition, the firm’s Vessi system comprises a standalone console and a disposable catheter for transurethral insertion into the bladder, allowing for visualization and treatment without the need for anaesthesia in some cases. The company plans to use the funding from February 2024 to support expansion of its capabilities, clinical studies in Israel and the U.
S. , and regulatory clearance.
Current Investors
Trendlines Group, Israel Innovation Authority, ExitValley
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.vessimed.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.